Related Experiment Video

Updated: Oct 2, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

MYCN Amplification in Neuroblastoma: a Paradigm for the Clinical Use of an Oncogene

Manfred Schwab1

  • 1German Cancer Research Center, Division of Cytogenetics, Heidelberg, Germany.

Pathology Oncology Research : POR
|January 1, 1997
PubMed

Insights

Amplifying cellular oncogenes, like MYCN in neuroblastoma, signals aggressive cancers. MYCN amplification predicts poor prognosis and guides specific therapeutic regimens for patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • DNA amplification of cellular oncogenes is a common genetic alteration in cancer.
  • Chromosomal abnormalities such as double minutes (DMs) or homogeneously staining chromosomal regions (HSRs) often indicate oncogene amplification.
  • Specific amplified oncogenes occur at high frequencies in certain human cancers.

Purpose of the Study:

  • To investigate the role of MYCN amplification in neuroblastoma.
  • To determine the prognostic and predictive value of MYCN amplification in neuroblastoma patients.

Main Methods:

  • Analysis of chromosomal abnormalities in cancer cells.
  • Detection and quantification of specific oncogene amplification (MYCN).
  • Correlation of genetic findings with clinical outcomes and treatment response.

Main Results:

  • MYCN amplification is frequently observed in aggressive neuroblastomas.
  • MYCN amplification is associated with a poor prognosis in neuroblastoma patients.
  • MYCN amplification serves as a predictive marker for treatment response.

Conclusions:

  • MYCN amplification is a significant indicator of aggressive neuroblastoma and poor prognosis.
  • Identifying MYCN amplification is crucial for tailoring therapeutic strategies.
  • This genetic marker helps in selecting patients who will benefit from specific treatments and those unlikely to respond to chemotherapy.

More Related Videos

Zebrafish Model of Neuroblastoma Metastasis05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...